GMED
NYSE
Health Care
$80.50
USD
+$0.38 (+0.47%)
At close: Jul 6, 2026, 4:00 PM EDT
Market Cap:
$10.87B
Volume:
1.1M
Previous Close
$80.12
Day Range
$78.25 - $81.16
52 Week Range
$51.79 - $101.40
Average Volume (10 Days)
2.3M
P/E Ratio
20.21
Dividend Yield
—
Globus Medical, Inc. operates as a medical device company that develops and commercializes healthcare solutions. The company is headquartered in Audubon, Pennsylvania and currently employs 6,000 full-time employees. The company went IPO on 2012-03-08. The firm provides education and clinical support, and advanced care throughout spine, orthopedic trauma, joint reconstruction, biomaterials and enabling technologies. The firm offers a comprehensive portfolio of technologies that address a variety of musculoskeletal pathologies, anatomies, and surgical approaches. The company separates its products and services into two major categories: Musculoskeletal Solutions and Enabling Technologies. Its Musculoskeletal Solutions consist primarily of implantable devices, biologics, accessories, surgical instruments, spinal cord stimulation treatment therapy, and neuromonitoring services, used in an expansive range of spinal, orthopedic and neurosurgical procedures. Its Enabling Technologies are comprised of imaging, navigation and robotics (INR) solutions for assisted surgery which are advanced computer-assisted intelligent systems designed to enhance a surgeon’s capabilities.
CEO
Mr. Keith Pfeil
Headquaters
Audubon, PENNSYLVANIA, US
Founded
2012
Employees
6,000
ZBH
Zimmer Biomet Holdings, Inc
$89.76
+2.6%
NVST
Envista Holdings Corp
$27.51
-0.4%